SouthState Corp’s Evolus EOLS Stock Holding History

SouthState Corp’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-217	Closed	-$2.61K	–	1663
2025 Q1	$2.61K	Buy	+217	New	+$2.84K	﹤0.01%	1126

Other funds holding EOLS

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SouthState Corp's EOLS Position: Q2 2025 in Review

SouthState Corp sold out of Evolus (EOLS) in Q2 2025, closing a stake of 217 shares — an estimated $2.61K sold.

SouthState Corp first reported a position in EOLS in Q1 2025 and held it in 1 quarter. The position peaked at $2.61K in Q1 2025. 172 funds tracked by Wall St. Rank hold EOLS as of Q2 2025.

SouthState Corp reported no remaining Evolus position as of Q2 2025 after selling out during the quarter.
SouthState Corp sold 217 Evolus shares in Q2 2025, an estimated $2.61K.
SouthState Corp first reported a position in Evolus in Q1 2025 and held it in 1 quarter.
SouthState Corp's Evolus position peaked at $2.61K in Q1 2025.
172 funds tracked by Wall St. Rank held Evolus as of Q2 2025.

Based on SouthState Corp's 13F filing for Q2 2025, filed 6 Aug 2025.